Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2025 | Evaluating the benefits of early diagnosis in prostate cancer

Massimo Lazzeri, MD, PhD, Humanitas University, Milan, Italy, highlights the benefits of early diagnosis in localized prostate cancer, allowing for conservative treatments like focal therapy, which can preserve potency, continence, and ejaculation, and maintain the patient’s quality of life. This approach is innovative and beneficial for patients, enabling them to avoid more invasive treatments like surgery or radiotherapy. This interview took place at the ASCO GU Cancers Symposium 2025 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

The benefit for the patient to receive an early diagnosis in a localized situation in which we can offer conservative treatments, for instance, such as the focal therapy, which avoids removing the whole gland by surgery or to treat the whole gland by radiotherapy. And so it’s very, very innovative and it’s a beneficial effect for the patient which can maintain potency, continence and ejaculation if he receives an early diagnosis and a conservative treatment such as focal therapy...

The benefit for the patient to receive an early diagnosis in a localized situation in which we can offer conservative treatments, for instance, such as the focal therapy, which avoids removing the whole gland by surgery or to treat the whole gland by radiotherapy. And so it’s very, very innovative and it’s a beneficial effect for the patient which can maintain potency, continence and ejaculation if he receives an early diagnosis and a conservative treatment such as focal therapy.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...